An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma is a research paper published in Bioengineering & Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA225103
National Institutes of Health
Grant: 1T32GM136568-01A1
Molecular Biophysics Training Program at Stanford
National Institutes of Health
Grant: 5T32CA009302-17
CANCER ETIOLOGY PREVENTION DETECTION AND DIAGNOSIS
National Institutes of Health
Grant: 2T32GM008294-11
MOLECULAR BIOPHYSICS TRAINING PROGRAM
National Institutes of Health
Grant: 1R01CA225103-01A1
Development of novel protein-based therapeutics for lung cancer
NCI NIH HHS
Grant: T32 CA009302
NIGMS NIH HHS
Grant: T32 GM008294
NIGMS NIH HHS
Grant: T32 GM136568
FWCI
0.58
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals